1 Product identity

Ingredient risk

3 ingredients to use with caution

Koios

Name: Koios
Brand: Koios

BrandKoios→Other Combinations Capsule 15 ingredients 3 caution DSLD #54035

Net contents: 60 Capsule(s)

Target: Adults and Children 4 years and above

DSLD entry: 2015-11-24

2 Ingredients (15)

IngredientGroupSafety

Vitamin B6Vitamin B6Use with Caution

Vitamin B12Vitamin B12Use with Caution

Mental Titan BlendProprietary Blend (Combination)—

Eleuthero root powderEleuthero—

L-TyrosineTyrosine—

Guarana seed extractGuarana —

Alpha GlycerylphosphorylcholineAlpha-GPC—

Bacopa leaf powderBacopaConditionally Safe

Phosphatidyl SerinePhosphatidylserineGenerally Safe

VinpocetineVinpocetine—

Huperzine AHuperzine—

HypromelloseHypromellose—

Dicalcium PhosphateCalciumConditionally Safe

Rice FlourRice—

Magnesium StearateMagnesiumUse with Caution

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Vitamin B6 — Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients…

Vitamin B12 — Nitrous oxide anesthesia in subclinically B12-deficient patients can precipitate acute combined degeneration — always check B12 before elective p…

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Vitamin B6 — Use with Caution

Vitamin B12 — Use with Caution

L-Tyrosine — Limited Evidence

⚠ May worsen hyperthyroidism

⚠ Migraine trigger in some

Choline — Limited Evidence

⚠ Fishy odor at high doses

Bacopa — Conditionally Safe

⚠ GI upset

⚠ May affect thyroid

Phosphatidylserine — Generally Safe

⚠ May enhance anticoagulant effects

⚠ Soy allergy risk (soy-derived)

Calcium — Conditionally Safe

⚠ Cardiovascular risk debated >1,000 mg/day

⚠ Kidney stones

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID54035

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2015-11-24

6 More from Koios

View Koios Safety Scorecard → 1 products

7 Cite this page

Vancouver

Pkhakadze G. Koios — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 31]. Available from: https://supplement.ge/products/koios-54035/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG